Latest Period
Q2 2026
Security Snapshot
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) Institutional Ownership
CUSIP: 09077V100
13F Institutional Holders and Ownership History from Q3 2024 to Q2 2026
Institutions Reporting
150
Shares (Excl. Options)
37,707,821
Price
$24.51
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- BIOA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 37,707,821
- Total 13F value
- $924,023,976
- Portfolio coverage rank
- 0%
- Share change
- +3,361,966
- Value change
- +$86,088,399
- Number of holders
- 150
- Shares outstanding
- 44,435,037
- SEC-reported price per share
- $24.84
- Insider filing price
- $24.84
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share is tracked under CUSIP 09077V100.
- 150 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 144 to 150 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $599,230,651 to $924,023,976.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 150 institutions filings for Q2 2026.
Security key
09077V100
Latest holder period
Q2 2026
13F holders
150
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
BIOA full holder history
BioAge Labs, Inc. SEC filings
BioAge Labs, Inc. company facts
BioAge Labs, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09077V100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
BIOA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fortney Kristen | 7.2% | $48,279,538 | 2,704,736 | Kristen Fortney | 31 Dec 2025 | |||
| Cormorant Asset Management, LP | 5.4% | -16% | $59,382,628 | -$12,420,000 | 2,390,605 | -17% | Cormorant Asset Management, LP | 30 Jun 2026 |
| BlackRock, Inc. | 5% | $39,115,685 | 2,236,460 | BlackRock, Inc. | 31 Mar 2026 | |||
| Khosla Ventures VI, L.P. | 4% | $29,120,985 | 1,798,702 | VK Services, LLC | 15 May 2026 | |||
| RA CAPITAL MANAGEMENT, L.P. | 3.7% | $5,740,380 | 1,310,589 | RA Capital Management, L.P. | 31 Dec 2024 | |||
| ADAR1 Capital Management, LLC | 0.4% | -100% | $2,419,746 | -$32,157,900 | 135,560 | -93% | ADAR1 Capital Management, LLC | 31 Dec 2025 |
As of 30 Jun 2026, 150 institutional investors reported holding 37,707,821 shares of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA). This represents 85% of the company’s total 44,435,037 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 7.3% | 3,233,170 | 0% | 0.56% | $79,244,997 |
| BlackRock, Inc. | 6.4% | 2,849,077 | +26% | 0% | $69,830,877 |
| Cormorant Asset Management, LP | 5.4% | 2,390,605 | -17% | 3% | $58,593,729 |
| Sofinnova Investments, Inc. | 5.2% | 2,293,788 | 0% | 3% | $56,220,744 |
| Jupiter Topco LLC | 4.8% | 2,144,633 | 0% | 0.02% | $52,597,124 |
| Octagon Capital Advisors LP | 3.9% | 1,748,000 | 0% | 3.9% | $42,843,480 |
| RA CAPITAL MANAGEMENT, L.P. | 3.8% | 1,671,648 | +1.3% | 0.36% | $40,972,092 |
| MPM BIOIMPACT LLC | 3.8% | 1,667,661 | 2.5% | $40,874,371 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 1,544,214 | +14% | 0% | $37,848,685 |
| Polar Capital Holdings Plc | 2.4% | 1,072,344 | -5.3% | 0.07% | $26,283,151 |
| BRAIDWELL LP | 2.3% | 1,033,129 | -14% | 0.94% | $25,321,992 |
| STATE STREET CORP | 2.3% | 1,021,464 | +20% | 0% | $25,036,083 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,004,264 | +34% | 0% | $24,619,235 |
| Sands Capital Alternatives, LLC | 1.8% | 786,353 | 0% | 3.1% | $19,273,512 |
| ORBIMED ADVISORS LLC | 1.7% | 752,153 | +5.7% | 0.35% | $18,435,270 |
| D. E. Shaw & Co., Inc. | 1.7% | 742,761 | +6.2% | 0.01% | $18,205,072 |
| Balyasny Asset Management L.P. | 1.6% | 702,858 | -47% | 0.03% | $17,227,050 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.5% | 653,374 | 0% | 5.2% | $16,014,197 |
| COSMIC MANAGEMENT, LLC | 1.1% | 501,833 | 0% | 3.2% | $12,299,927 |
| STEMPOINT CAPITAL LP | 1% | 464,171 | +37% | 2% | $11,376,831 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.92% | 410,165 | +43% | 0% | $10,053,144 |
| DIMENSIONAL FUND ADVISORS LP | 0.89% | 394,138 | +84% | 0% | $9,661,958 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.85% | 377,085 | -10% | 0.03% | $9,242,353 |
| Walleye Capital LLC | 0.8% | 354,395 | +134% | 0.04% | $8,686,221 |
| Nuveen, LLC | 0.79% | 349,142 | +617% | 0% | $8,557,471 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Latest
Q2 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 37,707,821 | $924,023,976 | +$86,088,399 | $24.51 | 150 |
| 2026 Q1 | 34,288,673 | $599,230,651 | +$183,047,150 | $17.49 | 144 |
| 2025 Q4 | 23,662,525 | $314,117,431 | +$36,761,604 | $13.23 | 113 |
| 2025 Q3 | 21,259,082 | $125,003,330 | +$3,516,038 | $5.88 | 92 |
| 2025 Q2 | 20,716,453 | $85,559,282 | +$3,327,577 | $4.13 | 81 |
| 2025 Q1 | 20,278,591 | $76,157,053 | +$1,658,645 | $3.76 | 65 |
| 2024 Q4 | 19,641,111 | $113,720,000 | -$68,696,192 | $5.79 | 64 |
| 2024 Q3 | 20,709,688 | $430,774,211 | +$424,388,861 | $20.80 | 58 |